End-of-day quote
Korea S.E.
06:00:00 2024-07-11 pm EDT
|
5-day change
|
1st Jan Change
|
8,800
KRW
|
+0.34%
|
|
-2.00%
|
-1.90%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
140,875
|
152,786
|
136,597
|
137,377
|
105,977
|
88,329
|
Enterprise Value (EV)
1 |
57,650
|
99,150
|
95,391
|
101,386
|
-28,014
|
14,770
|
P/E ratio
|
4.94
x
|
18.7
x
|
-83.6
x
|
17.2
x
|
2.43
x
|
-37.4
x
|
Yield
|
4.08%
|
1.04%
|
-
|
1.14%
|
4.21%
|
-
|
Capitalization / Revenue
|
1.4
x
|
2.11
x
|
1.88
x
|
1.66
x
|
1.96
x
|
2.17
x
|
EV / Revenue
|
0.57
x
|
1.37
x
|
1.31
x
|
1.22
x
|
-0.52
x
|
0.36
x
|
EV / EBITDA
|
1.54
x
|
7.3
x
|
10.1
x
|
7.24
x
|
-2.23
x
|
-18.1
x
|
EV / FCF
|
-12.3
x
|
-4.37
x
|
-9.33
x
|
-7.27
x
|
-2.45
x
|
-0.29
x
|
FCF Yield
|
-8.1%
|
-22.9%
|
-10.7%
|
-13.8%
|
-40.8%
|
-351%
|
Price to Book
|
1
x
|
1.08
x
|
0.99
x
|
0.93
x
|
0.55
x
|
0.48
x
|
Nbr of stocks (in thousands)
|
9,991
|
9,921
|
9,722
|
9,813
|
9,813
|
9,847
|
Reference price
2 |
14,100
|
15,400
|
14,050
|
14,000
|
10,800
|
8,970
|
Announcement Date
|
3/7/19
|
3/18/20
|
3/23/21
|
3/21/22
|
3/21/23
|
3/20/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
100,499
|
72,495
|
72,742
|
82,772
|
53,991
|
40,761
|
EBITDA
1 |
37,377
|
13,583
|
9,467
|
14,007
|
12,563
|
-814.9
|
EBIT
1 |
33,826
|
8,520
|
187.6
|
3,948
|
2,554
|
-8,468
|
Operating Margin
|
33.66%
|
11.75%
|
0.26%
|
4.77%
|
4.73%
|
-20.77%
|
Earnings before Tax (EBT)
1 |
35,901
|
10,743
|
-3,085
|
6,409
|
3,080
|
-3,969
|
Net income
1 |
28,770
|
8,230
|
-1,641
|
7,973
|
43,694
|
-2,357
|
Net margin
|
28.63%
|
11.35%
|
-2.26%
|
9.63%
|
80.93%
|
-5.78%
|
EPS
2 |
2,853
|
824.0
|
-168.0
|
814.0
|
4,453
|
-239.6
|
Free Cash Flow
1 |
-4,671
|
-22,712
|
-10,227
|
-13,947
|
11,417
|
-51,804
|
FCF margin
|
-4.65%
|
-31.33%
|
-14.06%
|
-16.85%
|
21.15%
|
-127.09%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
90.88%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
26.13%
|
-
|
Dividend per Share
2 |
575.0
|
160.0
|
-
|
160.0
|
455.0
|
-
|
Announcement Date
|
3/7/19
|
3/18/20
|
3/23/21
|
3/21/22
|
3/21/23
|
3/20/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
83,225
|
53,635
|
41,207
|
35,991
|
133,991
|
73,559
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-4,671
|
-22,712
|
-10,227
|
-13,947
|
11,417
|
-51,804
|
ROE (net income / shareholders' equity)
|
22.4%
|
5.55%
|
-2.47%
|
5.39%
|
1.01%
|
-1.46%
|
ROA (Net income/ Total Assets)
|
14.4%
|
3.39%
|
0.07%
|
1.55%
|
0.84%
|
-2.55%
|
Assets
1 |
200,341
|
242,680
|
-2,208,109
|
514,618
|
5,219,735
|
92,284
|
Book Value Per Share
2 |
14,083
|
14,240
|
14,188
|
15,088
|
19,540
|
18,831
|
Cash Flow per Share
2 |
8,330
|
5,553
|
4,435
|
3,475
|
12,018
|
1,140
|
Capex
1 |
19,278
|
36,341
|
18,763
|
22,036
|
21,582
|
34,680
|
Capex / Sales
|
19.18%
|
50.13%
|
25.79%
|
26.62%
|
39.97%
|
85.08%
|
Announcement Date
|
3/7/19
|
3/18/20
|
3/23/21
|
3/21/22
|
3/21/23
|
3/20/24
|
|
1st Jan change
|
Capi.
|
---|
| -1.90% | 63M | | +24.08% | 69.82B | | -3.00% | 47.07B | | +25.57% | 45.02B | | +34.90% | 29.69B | | +7.71% | 20.18B | | -23.96% | 15.22B | | -8.45% | 15.2B | | -28.89% | 12.16B | | +26.68% | 12.02B |
Other Specialty Chemicals
|